Merih Güray

1.3k total citations
22 papers, 843 citations indexed

About

Merih Güray is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Merih Güray has authored 22 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Merih Güray's work include Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (5 papers). Merih Güray is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Breast Lesions and Carcinomas (6 papers) and HER2/EGFR in Cancer Research (5 papers). Merih Güray collaborates with scholars based in Türkiye, United States and Austria. Merih Güray's co-authors include Ayşegül A. Şahin, Thomas A. Buchholz, Gabriel N. Hortobágyi, Ana M. González-Angulo, Vicente Valero, Kristine Broglio, Emer O. Hanrahan, Martine Piccart, Fátima Cardoso and Heidi Stranzl and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Merih Güray

21 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merih Güray Türkiye 11 435 421 290 153 136 22 843
Shoshu Mitsuyama Japan 16 293 0.7× 337 0.8× 216 0.7× 52 0.3× 143 1.1× 82 737
Marilin Rosa United States 16 281 0.6× 345 0.8× 347 1.2× 54 0.4× 166 1.2× 92 890
Anna W. Poniecka United States 11 832 1.9× 689 1.6× 439 1.5× 337 2.2× 171 1.3× 16 1.4k
Kotaro Iijima Japan 18 487 1.1× 503 1.2× 276 1.0× 103 0.7× 153 1.1× 59 873
Masujiro Makita Japan 18 588 1.4× 447 1.1× 500 1.7× 91 0.6× 244 1.8× 69 1.0k
D. Faverly Belgium 12 679 1.6× 389 0.9× 551 1.9× 130 0.8× 250 1.8× 32 1.1k
Jerzy Jakubowicz Poland 15 295 0.7× 325 0.8× 248 0.9× 157 1.0× 141 1.0× 58 931
Mary Morrogh United States 14 416 1.0× 276 0.7× 406 1.4× 126 0.8× 115 0.8× 20 745
Marcia Edelweiss United States 20 484 1.1× 392 0.9× 484 1.7× 139 0.9× 372 2.7× 50 1.1k
Rouzan G. Karabakhtsian United States 13 181 0.4× 180 0.4× 221 0.8× 56 0.4× 115 0.8× 34 599

Countries citing papers authored by Merih Güray

Since Specialization
Citations

This map shows the geographic impact of Merih Güray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merih Güray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merih Güray more than expected).

Fields of papers citing papers by Merih Güray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merih Güray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merih Güray. The network helps show where Merih Güray may publish in the future.

Co-authorship network of co-authors of Merih Güray

This figure shows the co-authorship network connecting the top 25 collaborators of Merih Güray. A scholar is included among the top collaborators of Merih Güray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merih Güray. Merih Güray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alıcıkuş, Zümre Arıcan, et al.. (2019). Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(4). 1151–1156.
2.
Güray, Merih, et al.. (2014). Characterization of immunohistochemical markers in triple negative breast carcinomas.. PubMed. 18(4). 886–90. 5 indexed citations
3.
Tuzlalı, Sıtkı, Ekrem Yavuz, Tülay Canda, et al.. (2014). In situ hybridization analysis of invasive breast carcinomas with immunohistochemically negative her-2 status (a national multicenter study). Turkish Journal of Pathology. 30(2). 87–87. 2 indexed citations
4.
Güray, Merih, et al.. (2014). Immunohistochemical analysis of thyroid follicular neoplasms and BRAF mutation correlation. Indian Journal of Cancer. 51(1). 63–63. 4 indexed citations
5.
Albert, Jeffrey M., Ana M. González-Angulo, Merih Güray, et al.. (2010). Estrogen/Progesterone Receptor Negativity and HER2 Positivity Predict Locoregional Recurrence in Patients With T1a,bN0 Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 77(5). 1296–1302. 58 indexed citations
7.
Sevınç, Ali Ibrahim, Tarkan Ünek, Aras Emre Canda, et al.. (2010). Papillary carcinoma arising in subhyoid ectopic thyroid gland with no orthotopic thyroid tissue. The American Journal of Surgery. 200(1). e17–e18. 12 indexed citations
8.
Altinel, Deniz, et al.. (2009). Langerhans cell histiocytosis of the cervical spine in an adult: a case report. Turkish Neurosurgery. 20(3). 409–12. 9 indexed citations
9.
González-Angulo, Ana M., Jennifer K. Litton, Kristine Broglio, et al.. (2009). High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller. Journal of Clinical Oncology. 27(34). 5700–5706. 334 indexed citations
11.
Balci, Pınar, et al.. (2007). Breast Myxoma: Radiologic and Histopathologic Features. The Breast Journal. 13(1). 88–90. 10 indexed citations
12.
Güray, Merih & Ayşegül A. Şahin. (2005). Metaplastic Breast Carcinomas: Are They of Myoepithelial Differentiation? Immunohistochemical Profile of the Sarcomatoid Subtype Using Novel Myoepithelial Markers. Breast Diseases A Year Book Quarterly. 16(4). 359–359. 2 indexed citations
13.
Güray, Merih, et al.. (2004). Association of Invasive Breast Carcinoma and Glioblastoma Multiforme: a Case Report with Histological and Immunohistochemical Features. TURKISH JOURNAL OF MEDICAL SCIENCES. 34(2). 131–135. 2 indexed citations
14.
Çam, Fethi Sırrı & Merih Güray. (2004). Hypertrophic cardiomyopathy: pathological features and molecular pathogenesis.. PubMed. 4(4). 327–30. 6 indexed citations
15.
Güray, Merih, et al.. (2003). The Pathology of Echinococcosis and the Current Echinococcosis Problem in Western Turkey (A Report of Pathologic Features in 80 Cases). TURKISH JOURNAL OF MEDICAL SCIENCES. 33(6). 369–374. 24 indexed citations
16.
Güray, Merih, Sülen Sarıoğlu, Mehmet Türkmen, et al.. (2003). Cyclosporine a toxicity in association with reduced renal mass. Transplantation Proceedings. 35(8). 3128–3133. 8 indexed citations
17.
Tuna, Burçin, Kutsal Yörükoğlu, Emre Tüzel, et al.. (2003). Expression of p53 and mdm2 and Their Significance in Recurrence of Superficial Bladder Cancer. Pathology - Research and Practice. 199(5). 323–328. 21 indexed citations
18.
Özer, Erdener, et al.. (2003). Expression of BCL-2, BAX and P53 Proteins in Pituitary Adenomas an Immunohistochemical Study. Tumori Journal. 89(1). 54–59. 30 indexed citations
19.
Sağol, Özgül, Kutsal Yörükoğlu, B. Sis, et al.. (2001). Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?. Urology. 57(5). 895–899. 20 indexed citations
20.
Güray, Merih, et al.. (2001). The histopathologic and the immunohistochemical features of secretory meningiomas. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026